Show simple item record

Autosomal dominant tubulointerstitial kidney disease: A review

dc.contributor.authorŽivná, Martina
dc.contributor.authorKidd, Kendrah Osborne
dc.contributor.authorBarešová, Veronika
dc.contributor.authorHůlková, Helena
dc.contributor.authorKmoch, Stanislav
dc.contributor.authorBleyer, Anthony
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.14178/1696
dc.description.abstractThe clinical characteristics of autosomal dominant tubulointerstitial kidney disease (ADTKD) include bland urinary sediment, slowly progressive chronic kidney disease (CKD) with many patients reaching end stage renal disease (ESRD) between age 20 and 70 years, and autosomal dominant inheritance. Due to advances in genetic diagnosis, ADTKD is becoming increasingly recognized as a cause of CKD. Pathogenic variants in UMOD, MUC1, and REN are the most common causes of ADTKD. ADTKD-UMOD is also associated with hyperuricemia and gout. ADTKD-REN often presents in childhood with mild hypotension, CKD, hyperkalemia, acidosis, and anemia. ADTKD-MUC1 patients present only with CKD. This review describes the pathophysiology, genetics, clinical manifestation, and diagnosis for ADTKD, with an emphasis on genetic testing and genetic counseling suggestions for patients.en
dc.language.isoen
dc.relation.urlhttps://doi.org/10.1002/ajmg.c.32008
dc.rightsCreative Commons Uveďte původ-Neužívejte dílo komerčně-Nezpracovávejte 4.0 Internationalcs
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivativeWorks 4.0 Internationalen
dc.titleAutosomal dominant tubulointerstitial kidney disease: A reviewen
dcterms.accessRightsopenAccess
dcterms.licensehttps://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
dc.date.updated2023-10-02T06:12:53Z
dc.subject.keywordAutosomal Dominant Tubulointerstitial Kidney Diseaseen
dc.subject.keywordMUC1en
dc.subject.keywordUMODen
dc.subject.keywordRENen
dc.subject.keyworden
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MZ0/NU/NU21-07-00033
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM/LT/LTAUSA19068
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/UK/UNCE/MED/UNCE/MED/007
dc.relation.fundingReferenceinfo:eu-repo/grantAgreement/MSM//LX22NPO5104
dc.date.embargoStartDate2023-10-02
dc.type.obd73
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doi10.1002/ajmg.c.32008
dc.identifier.utWos000868552600001
dc.identifier.eidScopus2-s2.0-85139913854
dc.identifier.obd617342
dc.identifier.rivRIV/00216208:11110/22:10449683
dc.identifier.pubmed36250282
dc.subject.rivPrimary30000::30100::30101
dcterms.isPartOf.nameAmerican Journal of Medical Genetics: Part C, Seminars in Medical Genetics
dcterms.isPartOf.issn1552-4868
dcterms.isPartOf.journalYear2022
dcterms.isPartOf.journalVolume190
dcterms.isPartOf.journalIssue3
uk.faculty.primaryId108
uk.faculty.primaryName1. lékařská fakultacs
uk.faculty.primaryNameFirst Faculty of Medicineen
uk.department.primaryId1522
uk.department.primaryNameKlinika pediatrie a dědičných poruch metabolismu 1. LF a VFNcs
uk.department.primaryNameDepartment of Paediatrics and Inherited Metabolic Disorders 1. LF UK a VFNen
dc.description.pageRange309-324
dc.type.obdHierarchyCsČLÁNEK V ČASOPISU::článek v časopisu::přehledový článekcs
dc.type.obdHierarchyEnJOURNAL ARTICLE::journal article::summarizing articleen
dc.type.obdHierarchyCode73::152::205en
uk.displayTitleAutosomal dominant tubulointerstitial kidney disease: A reviewen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record